Humanin derivative, HNG, enhances neurotransmitter release

Area of Science:

• Neuroscience
• Molecular Biology
• Pharmacology

Background:

• Humanin (HN) is an endogenous peptide protecting against neuronal death in Alzheimer's disease (AD).
• HN derivative HNG ameliorated cognitive impairment in AD mouse models.
• Mechanisms underlying HN's cognitive benefits require elucidation.

Purpose of the Study:

• To investigate the molecular mechanisms by which Humanin (HN) and its derivative HNG improve cognitive function.
• To determine if HN directly influences neurotransmitter release and exocytosis.
• To explore the role of HN in regulating neuronal secretory pathways.

Main Methods:

• Extracellular hippocampal fluid collected via microdialysis in mice.
• Neurotransmitter levels measured.
• Amperometry used for kinetic analysis of exocytosis in neuroendocrine cells.
• In vitro studies using PC12 cells and primary neuroendocrine cells.

Main Results:

• HNG administration increased hippocampal acetylcholine (ACh) levels in mice.
• HNG improved object memory without affecting physical activity.
• HNG enhanced ACh-induced dopamine release in PC12 cells.
• HNG increased ACh-induced secretory events and vesicular quantal size in primary neuroendocrine cells.

Conclusions:

• Humanin (HN) directly enhances regulated exocytosis in neurons.
• This mechanism contributes to the cognitive-enhancing effects of HN.
• HN's role as a regulator of exocytosis provides a molecular basis for its impact on brain function in health and disease.